Literature DB >> 17709203

Beta-amyloid toxicity and reversal in embryonic rat septal neurons.

Karen Jarvis1, Poincyane Assis-Nascimento, Laura M Mudd, Jeremy R Montague.   

Abstract

Alzheimer's disease is characterized mainly by loss of neurons from the septal nucleus. In this study, neurons from the septal nucleus of the embryonic day 16 (E16) rat were grown in culture with a plane of astrocytes from the embryonic rat and in a defined medium in the absence of serum. Neurons were treated with beta-amyloid (Abeta: 0.1, 1 and 10 microM) on day in vitro (DIV) 1 and DIV 4 and fluorescent microscopy was used to measure survival and apoptosis following exposure of the treated cells on DIV 7. Reversal of neurotoxicity was studied using the potentially neuroprotective agents nerve growth factor (NGF, 100 ng/ml), basic fibroblast growth factor (bFGF, 5 ng/ml), insulin-like growth factors (IGF1 and IGF2, 10 ng/ml) and estrogen (10 nM), administered on DIV 4 and DIV 5, that is, subsequent to the Abeta (10 microM)-induced neurotoxicity. Abeta caused a significant decrease in survival at 10 microM, and a significant increase in apoptosis at 0.1 and 10 microM. IGF1, IGF2 and bFGF all caused a reversal of the Abeta-induced neurotoxic effect on survival while NGF and estrogen did not under these experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709203      PMCID: PMC2751578          DOI: 10.1016/j.neulet.2007.06.058

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

Review 1.  Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.

Authors:  J W Simpkins; P S Green; K E Gridley; M Singh; N C de Fiebre; G Rajakumar
Journal:  Am J Med       Date:  1997-09-22       Impact factor: 4.965

2.  beta-Amyloid 25-35 activates nitric oxide synthase in a neuronal clone.

Authors:  J Hu; E E el-Fakahany
Journal:  Neuroreport       Date:  1993-06       Impact factor: 1.837

3.  Lymphocytes as cell model to study apoptosis in Alzheimer's disease: vulnerability to programmed cell death appears to be altered.

Authors:  A Eckert; C W Cotman; R Zerfass; M Hennerici; W E Müller
Journal:  J Neural Transm Suppl       Date:  1998

4.  Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

Authors:  S Doré; S Kar; R Quirion
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 5.  Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy.

Authors:  M P Mattson; S W Scheff
Journal:  J Neurotrauma       Date:  1994-02       Impact factor: 5.269

6.  Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

Authors:  M P Mattson; K J Tomaselli; R E Rydel
Journal:  Brain Res       Date:  1993-09-03       Impact factor: 3.252

Review 7.  Role of serum insulin-like growth factor I in mammalian brain aging.

Authors:  Jose Luis Trejo; Eva Carro; Cristina Lopez-Lopez; Ignacio Torres-Aleman
Journal:  Growth Horm IGF Res       Date:  2004-06       Impact factor: 2.372

8.  Neurite outgrowth of neuroblastoma cells induced by proteins covalently coupled to glass coverslips.

Authors:  J Jousimaa; J Merenmies; H Rauvala
Journal:  Eur J Cell Biol       Date:  1984-09       Impact factor: 4.492

9.  Astrocyte modulation of in vitro beta-amyloid neurotoxicity.

Authors:  Silvia Paradisi; Benedetto Sacchetti; Maria Balduzzi; Simona Gaudi; Fiorella Malchiodi-Albedi
Journal:  Glia       Date:  2004-05       Impact factor: 7.452

Review 10.  Increased apoptotic cell death in sporadic and genetic Alzheimer's disease.

Authors:  Anne Eckert; Celio A Marques; Uta Keil; Katrin Schüssel; Walter E Müller
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

View more
  10 in total

1.  Sphingosine kinase-1 protects differentiated N2a cells against beta-amyloid25-35-induced neurotoxicity via the mitochondrial pathway.

Authors:  Yang Yang; Min Wang; Bingjie Lv; Rong Ma; Jing Hu; Yaoyan Dun; Shenggang Sun; Gang Li
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996

2.  Tanshinone IIA protects PC12 cells from β-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway.

Authors:  Huimin Dong; Shanping Mao; Shanpin Mao; Jiajun Wei; Baohui Liu; Zhaohui Zhang; Qian Zhang; Mingmin Yan
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

3.  Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Authors:  Bronwen Martin; Wayne Chadwick; Wei-na Cong; Nick Pantaleo; Caitlin M Daimon; Erin J Golden; Kevin G Becker; William H Wood; Olga D Carlson; Josephine M Egan; Stuart Maudsley
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

4.  The effects of amyloid-β42 oligomer on the proliferation and activation of astrocytes in vitro.

Authors:  Lingling Hou; Yanfeng Liu; Xiaoyu Wang; Haibin Ma; Jinsheng He; Ying Zhang; Changhai Yu; Weijun Guan; Yuehui Ma
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-08-20       Impact factor: 2.416

5.  BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid β-induced toxicity in cultured rat septal neurons.

Authors:  Narisorn Kitiyanant; Yindee Kitiyanant; Clive N Svendsen; Wipawan Thangnipon
Journal:  Neurochem Res       Date:  2011-09-11       Impact factor: 3.996

Review 6.  Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.

Authors:  Y Wang; R G MacDonald; G Thinakaran; S Kar
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

7.  Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function.

Authors:  Luis V Colom; Maria T Castañeda; Cristina Bañuelos; Gustavo Puras; Antonio García-Hernández; Sofia Hernandez; Suzanne Mounsey; Joy Benavidez; Claudia Lehker
Journal:  Neurobiol Aging       Date:  2008-06-10       Impact factor: 4.673

8.  Neuroprotective effects of LMW and HMW FGF2 against amyloid beta toxicity in primary cultured hippocampal neurons.

Authors:  Yong Cheng; Zhaojin Li; Elissavet Kardami; Y Peng Loh
Journal:  Neurosci Lett       Date:  2016-08-18       Impact factor: 3.046

9.  Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson's disease.

Authors:  Denisse Sepúlveda; Felipe Grunenwald; Alvaro Vidal; Paulina Troncoso-Escudero; Marisol Cisternas-Olmedo; Roque Villagra; Pedro Vergara; Carlos Aguilera; Melissa Nassif; Rene L Vidal
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.379

10.  IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.

Authors:  Tiffany J Mellott; Sarah M Pender; Rebecca M Burke; Erika A Langley; Jan Krzysztof Blusztajn
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.